Cell & Gene Therapy Manufacturing Services Market Report 2026

Cell & Gene Therapy Manufacturing Services Market Overview

• Cell & Gene Therapy Manufacturing Services market size has reached to $9.44 billion in 2025 • Expected to grow to $21.05 billion in 2030 at a compound annual growth rate (CAGR) of 17.4% • Growth Driver: Rising Prevalence Of Cancer And Other Target Diseases To Drive Market Growth • Market Trend: Technological Advancements Driving Innovation In Cell And Gene Therapy Manufacturing Services Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Cell & Gene Therapy Manufacturing Services Market?

Cell and gene therapy manufacturing services refer to the manufacturing and quality-testing services for gene and cell therapy products. It aids in the advancement and production of remedies for degenerative illnesses, tissue injuries, and genetic abnormalities. These services include good manufacturing practices ancillary reagents, flow cytometry, immunoassays, and gene engineering services. The main types of cell and gene therapy manufacturing services include gene therapy and cell therapy. Gene therapy is a medical strategy that addresses the underlying genetic issue in order to treat or prevent disease. They are used for commercial manufacturing and clinical manufacturing applications for various indications including central nervous system disorders, ophthalmology diseases, cardiovascular diseases, infectious diseases, orthopedic diseases and oncology diseases. These services are used by academic and research institutes, pharmaceutical and biotechnology companies, and others.

What Is The Cell & Gene Therapy Manufacturing Services Market Growth Forecast?

The cell & gene therapy manufacturing services market size is expected to see rapid growth in the next few years. It will grow to $21.05 billion in 2030 at a compound annual growth rate (CAGR) of 17.4%. The growth in the forecast period can be attributed to increasing commercialization of cell and gene therapies, rising demand for large-scale manufacturing services, expansion of personalized medicine pipelines, increasing regulatory clarity for advanced therapies, growing investments in advanced therapy infrastructure. Major trends in the forecast period include expansion of gmp-compliant manufacturing capacity, growing adoption of automated cell processing systems, rising demand for scalable viral vector production, increasing integration of advanced quality control technologies, enhanced focus on manufacturing standardization.

Global Cell & Gene Therapy Manufacturing Services Market Segmentation

1) By Type: Gene Therapy, Cell Therapy 2) By Indication: Central Nervous System Disorders, Ophthalmology Diseases, Cardiovascular Diseases, Infectious Diseases, Orthopedic Diseases, Oncology Diseases 3) By Application: Commercial Manufacturing, Clinical Manufacturing 4) By End-user: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Other End-Users Subsegments: 1) By Gene Therapy: Viral Vector Manufacturing, Plasmid DNA Production, Gene Editing Services, Formulation And Fill-Finish Services 2) By Cell Therapy: Cell Sourcing And Banking, Cell Processing And Expansion, Quality Control And Testing Services, Cryopreservation And Storage Services

What Is The Driver Of The Cell & Gene Therapy Manufacturing Services Market?

The high incidence of cancer and other target diseases is expected to propel the growth of the cell and gene therapy manufacturing services market going forward. Cancer is a severe disorder in which the body's cells reproduce fast and uncontrollably, resulting in abnormal growth. Cell and gene therapies are developing as promising new strategies to combat the rising incidence of cancer, which is driving the demand for novel and efficient treatment choices. For instance, in February 2025, according to the American Cancer Society, a US-based nonprofit cancer advocacy organization, In the US in 2025, there will be an estimated 316,950 new cases of invasive breast cancer diagnosed in women and 2,800 cases in men. Therefore, the high incidence of cancer and other target diseases is driving the growth of the cell and gene therapy manufacturing services market going forward.

Key Players In The Global Cell & Gene Therapy Manufacturing Services Market

Major companies operating in the cell & gene therapy manufacturing services market are Thermo Fisher Scientific Inc., Merck KGaA, Charles River Laboratories International Inc., Lonza Group AG, Catalent Inc., WuXi AppTec, Takara Bio Inc., Fujifilm Holdings Corporation, Oxford Biomedica plc, Cell and Gene Therapy Catapult, Samsung Biologics Co. Ltd., BioNTech SE, Novartis International AG, Pfizer Inc., Boehringer Ingelheim International GmbH, Sarepta Therapeutics Inc., bluebird bio Inc., Precision BioSciences Inc., GSK plc, AstraZeneca plc, Bayer AG

Global Cell & Gene Therapy Manufacturing Services Market Trends and Insights

Major companies operating in the cell and gene therapy manufacturing services market are focusing on developing innovative biomanufacturing technologies to enhance scalability, production efficiency, and overall quality of cell and gene therapies. For instance, in September 2025, ARPA-H, a US-based government health agency, launched a program to ignite innovative biomanufacturing for cell and gene therapies. The program aims to accelerate the development of advanced manufacturing platforms, improve production yields, and enable cost-effective, scalable manufacturing of complex cell and gene therapy products. By supporting high-risk, high-reward technologies, the initiative is expected to drive innovation in biomanufacturing, strengthen the manufacturing ecosystem, and facilitate faster patient access to transformative therapies.

What Are Latest Mergers And Acquisitions In The Cell & Gene Therapy Manufacturing Services Market?

In June 2024, Genezen, a US-based gene and cell therapy company acquired UniQure for an undisclosed amount. With this acquisition, Genezen aims to enhance its capabilities in gene therapy production, expanding its portfolio of services and leveraging UniQure's expertise to meet the growing demand for innovative gene therapies in the market. UniQure is a Netherlands-based biotechnology company specializing in gene therapies for severe diseases.

Regional Outlook

North America was the largest region in the cell and gene therapy manufacturing services market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global cell & gene therapy manufacturing services market report forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Cell & Gene Therapy Manufacturing Services Market?

The cell and gene therapy manufacturing services market includes revenues earned by cell and gene therapy manufacturing and related services which include analytical and process development, current good manufacturing practice cell therapy manufacturing services of autologous and allogeneic t-cells, natural killer cells, dendritic cells, mesenchymal stem cells, hematopoietic stem cells, and more. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Cell & Gene Therapy Manufacturing Services Market Report 2026?

The cell & gene therapy manufacturing services market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the cell & gene therapy manufacturing services industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.